Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended release torsemide for OAB symptoms in CHF
NCT06206512Phase 2Completed
- Start
- Jun 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of torasemide in overactive bladder (OAB). Started Jun 2024; status: completed.
02
Drugs
torasemide
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT06206512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06206512.